In summary, these data show that BH3 mimetics are substrates of ABCC1 and that overexpression of ABCC1 limits the sensitivity of AML cells to BCL-2 inhibitors by reducing their intracellular concentration. This evidence concerns the gene BCL2 and acute myeloid leukemia.